在接受初级穿皮冠状动脉干预的ST段升高心肌梗塞患者中,比瓦利鲁丁加高剂量输液与单疗法:随机试验
Yi Li1, Zhenyang Liang1, Lei Qin2
1General Hospital of Northern Theater Command, Shenyang, China.
Lancet (London, England)
|November 9, 2022
概括
在接受穿皮冠状动脉干预 (PCI) 的ST段升高心肌梗塞 (STEMI) 患者中,比瓦利鲁丁抗凝剂显著降低了死亡率和严重出血. 在BRIGHT-4试验中,这种方法被证明比单独治疗的肝素更安全,更有效.
科学领域:
- 心血管医学
- 干预心脏病学
- 药理学
背景情况:
- 在接受初级穿皮冠状动脉干预 (PCI) 的ST段升高心肌梗塞 (STEMI) 患者中,比较了比瓦利鲁丁和肝素的先前试验结果存在矛盾.
- 在之前的研究中使用的不同药理疗法可能导致了这些相互矛盾的结果.
- 这项研究旨在根据先前的最佳安全性和疗效平衡,将比利鲁丁与PCI后的高剂量输液方案进行比较.
研究的目的:
- 对接受初级PCI的STEMI患者进行高剂量输注的疗效和安全性,与未分离的肝素单一治疗相比.
- 确定这些抗凝血策略对所有原因死亡率或重大出血 (BARC类型3-5) 的综合终点的影响.
主要方法:
- BRIGHT-4试验是一项由研究人员发起的,开放的,随机对照试验,涉及6016名接受初级PCI的STEMI患者.
- 患者接受了PCI后的高剂量输液 (2-4小时) 或未分离的肝素单一治疗.
- 主要终点是所有原因死亡率或30天出血学术研究联盟 (BARC) 3-5型出血的组合.
主要成果:
- 与肝素相比,比瓦利鲁丁显著降低了所有原因死亡率或BARC类型3-5出血的30天复合率 (3. 06%对4. 39%).
- 在比瓦利鲁丁组,全因死亡率较低 (2. 96% vs 3. 92%),而BARC类型3-5出血显著降低 (0. 17% vs 0. 80%).
- 与肝素相比,比瓦利鲁丁还显著减少了支架血栓形成的情况 (0. 37% vs 1. 10%).
结论:
- 在接受初级PCI的STEMI患者中,主要是放射性动脉接入,在PCI后输入高剂量的比瓦利鲁丁优于肝素单一治疗.
- 这种疗法显著降低了30天死亡率或严重出血率.
- 在这种患者群体中,比瓦利鲁丁具有良好的安全性和有效性.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
838
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
838
01:29Venous Thrombosis III: Interprofessional Care
18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
01:28Acute Coronary Syndrome IV: Interprofessional Care
22
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
01:30Acute Coronary Syndrome I: Introduction
56
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
01:28Cardiac Catheterization I: Pre-Procedure Overview
126
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
126
01:27Peripheral Artery Disease III: Interprofessional Care
19
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
19